{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:44:50Z","timestamp":1786963490350,"version":"build-2736575974"},"reference-count":33,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ulcerative colitis (UC) is a chronic inflammatory disease that affects the colon, triggering persistent inflammation and ulceration, resulting in a severe impact on patients\u2019 quality of life. Currently, the standard diagnostic methods for UC include invasive procedures such as colonoscopy and the use of non-specific inflammatory markers like C-reactive protein, which can be inconvenient or painful and lack specificity. This underscores the need for non-invasive and highly specific biomarkers for UC. MicroRNAs (miRNAs) are small non-coding RNAs, typically 22 nucleotides in length, which are well described as gene expression regulators. Several studies have reported their differential expression in various pathological conditions, including UC. Due to their role in gene regulation and stability in biological fluids, miRNAs present a promising opportunity as biomarkers. This systematic review explores the potential use of miRNAs as diagnostic biomarkers to distinguish between active and inactive ulcerative colitis. Following PRISMA guidelines and based on inclusion and exclusion criteria, seven studies, encompassing a total of 514 participants (181 with active UC and 116 with inactive UC), were included. Multiple miRNAs exhibiting differential expression between active and inactive UC were identified. Most notably, miR-21, miR-126, miR-146b-5p, and miR-223 exhibited consistent upregulation in active UC, suggesting their potential as diagnostic biomarkers. Supporting these findings is the fact that these miRNAs are involved in inflammatory pathways, further highlighting their relevance to the pathogenesis of UC. This review emphasizes the need for further validation studies with larger cohorts to confirm the utility of miRNAs as diagnostic tools for UC disease activity differentiation, which could enhance non-invasive disease monitoring and inform therapeutic decision-making. Future research should also evaluate the prognostic potential of these miRNAs for predicting treatment responses and long-term disease outcomes.<\/jats:p>","DOI":"10.3390\/ijms26146822","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T12:55:00Z","timestamp":1752670500000},"page":"6822","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Potential miRNAs as Diagnostic Biomarkers for Differentiating Disease States in Ulcerative Colitis: A Systematic Review"],"prefix":"10.3390","volume":"26","author":[{"given":"Atta Ullah","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Chacon-Millan","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5096-7488","authenticated-orcid":false,"given":"Paola","family":"Stiuso","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.mayocp.2019.01.018","article-title":"Ulcerative Colitis","volume":"94","author":"Feuerstein","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2023.15389","article-title":"Ulcerative Colitis in Adults: A Review","volume":"330","author":"Gros","year":"2023","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjx009","article-title":"Third European Evidence-Based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management","volume":"11","author":"Harbord","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG Clinical Guideline: Ulcerative Colitis in Adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100851","DOI":"10.1016\/j.disamonth.2019.02.004","article-title":"A Comprehensive Review and Update on Ulcerative Colitis","volume":"65","author":"Gajendran","year":"2019","journal-title":"Dis. Mon."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12664-023-01453-6","article-title":"Rapidly Changing Epidemiology of Inflammatory Bowel Disease: Time to Gear up for the Challenge before It Is Too Late","volume":"43","author":"Desai","year":"2024","journal-title":"Indian J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S00","DOI":"10.1093\/ibd\/izae020.085","article-title":"Trends in inflammatory bowel disease incidence and prevalence across epidemiologic stages: A global systematic review with meta-analysis","volume":"30","author":"Gorospe","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e036584","DOI":"10.1136\/bmjopen-2019-036584","article-title":"Incidence and Prevalence of Inflammatory Bowel Disease in UK Primary Care: A Population-Based Cohort Study","volume":"10","author":"Pasvol","year":"2020","journal-title":"BMJ Open"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00384-023-04417-6","article-title":"Trends in the Prevalence and Incidence of Ulcerative Colitis in Japan and the US","volume":"38","author":"Yamazaki","year":"2023","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Feng, X., Wang, H., Ye, S., Guan, J., Tan, W., Cheng, S., Wei, G., Wu, W., Wu, F., and Zhou, Y. (2012). Up-Regulation of microRNA-126 May Contribute to Pathogenesis of Ulcerative Colitis via Regulating NF-kappaB Inhibitor I\u03baB\u03b1. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0052782"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.3748\/wjg.v19.i27.4289","article-title":"MiR-20b, MiR-98, MiR-125b-1*, and Let-7e* as New Potential Diagnostic Biomarkers in Ulcerative Colitis","volume":"19","author":"Coskun","year":"2013","journal-title":"World J. Gastroenterol. WJG"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Van Der Goten, J., Vanhove, W., Lemaire, K., Van Lommel, L., Machiels, K., Wollants, W.J., De Preter, V., De Hertogh, G., Ferrante, M., and Van Assche, G. (2014). Integrated MiRNA and MRNA Expression Profiling in Inflamed Colon of Patients with Ulcerative Colitis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0116117"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/ibd\/izy046","article-title":"Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases","volume":"24","author":"Le","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.bbrc.2018.06.174","article-title":"Faecal MicroRNA as a Biomarker of the Activity and Prognosis of Inflammatory Bowel Diseases","volume":"503","author":"Ji","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apt.15159","article-title":"Circulating MicroRNA146b-5p Is Superior to C-Reactive Protein as a Novel Biomarker for Monitoring Inflammatory Bowel Disease","volume":"49","author":"Chen","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_18","first-page":"545","article-title":"Role of Circulating MicroRNA146b-5p and MicroRNA-106a in Diagnosing and Predicting the Severity of Inflammatory Bowel Disease","volume":"66","author":"Shaker","year":"2023","journal-title":"Egypt. J. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Shi, C., Liang, Y., Yang, J., Xia, Y., Chen, H., Han, H., Yang, Y., Wu, W., Gao, R., and Qin, H. (2013). MicroRNA-21 Knockout Improve the Survival Rate in DSS Induced Fatal Colitis through Protecting against Inflammation and Tissue Injury. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066814"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/j.gastro.2015.05.057","article-title":"MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice","volume":"149","author":"Polytarchou","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbrc.2013.03.122","article-title":"Overexpression of MiR-21 in Patients with Ulcerative Colitis Impairs Intestinal Epithelial Barrier Function through Targeting the Rho GTPase RhoB","volume":"434","author":"Yang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/MIB.0000000000001086","article-title":"Expression and Localization of MiR-21 and MiR-126 in Mucosal Tissue from Patients with Inflammatory Bowel Disease","volume":"23","author":"Andersen","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_23","first-page":"981","article-title":"The Role of the MiR-21-5p-Mediated Inflammatory Pathway in Ulcerative Colitis","volume":"19","author":"Lu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ibd\/izad181","article-title":"Expression of Circulating Let-7e and MiR-126 May Predict Clinical Remission in Patients With Crohn\u2019s Disease Treated With Anti-TNF-\u03b1 Biologics","volume":"30","author":"Guglielmi","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_25","first-page":"8345","article-title":"Reduced Serum MIR-98 Predicts Unfavorable Clinical Outcome of Colorectal Cancer","volume":"23","author":"Wang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2394249","DOI":"10.1080\/19490976.2024.2394249","article-title":"Fecal Let-7b and MiR-21 Directly Modulate the Intestinal Microbiota, Driving Chronic Inflammation","volume":"16","author":"Roy","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejphar.2016.04.044","article-title":"MiR-125b Inhibits Goblet Cell Differentiation in Allergic Airway Inflammation by Targeting SPDEF","volume":"782","author":"Liu","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Valmiki, S., Ahuja, V., Puri, N., and Paul, J. (2020). MiR-125b and MiR-223 Contribute to Inflammation by Targeting the Key Molecules of NF\u03baB Pathway. Front. Med., 6.","DOI":"10.3389\/fmed.2019.00313"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"107218","DOI":"10.1016\/j.intimp.2020.107218","article-title":"Inhibition of MiR-155 Alleviates Sepsis-Induced Inflammation and Intestinal Barrier Dysfunction by Inactivating NF-\u039aB Signaling","volume":"90","author":"Cao","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbrc.2017.04.143","article-title":"MiR-155 Contributes to Th17 Cells Differentiation in Dextran Sulfate Sodium (DSS)-Induced Colitis Mice via Jarid2","volume":"488","author":"Xu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"14966","DOI":"10.18632\/aging.103555","article-title":"MiR-155 Contributes to Intestinal Barrier Dysfunction in DSS-Induced Mice Colitis via Targeting HIF-1\u03b1\/TFF-3 Axis","volume":"12","author":"Liu","year":"2020","journal-title":"Aging"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.18632\/aging.205651","article-title":"Antagomir of MiR-31-5p Modulates Macrophage Polarization via the AMPK\/SIRT1\/NLRP3 Signaling Pathway to Protect against DSS-Induced Colitis in Mice","volume":"16","author":"Yuan","year":"2024","journal-title":"Aging"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.imbio.2011.08.005","article-title":"Expression of Let-7i Is Associated with Toll-like Receptor 4 Signal in Coronary Artery Disease: Effect of Statins on Let-7i and Toll-like Receptor 4 Signal","volume":"217","author":"Satoh","year":"2012","journal-title":"Immunobiology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/14\/6822\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:10:39Z","timestamp":1760033439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/14\/6822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":33,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["ijms26146822"],"URL":"https:\/\/doi.org\/10.3390\/ijms26146822","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]}}}